SCHEMBL19384747

SCHEMBL19384747

CC(C)(C)OC(=O)N[C@@H](CSSC[C@H](NC(=O)OC(C)(C)C)C(=O)OCC[Si](C)(C)C)C(=O)OCC[Si](C)(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.50
▸ CYP2C9 P11712 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ HTT P42858 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ CTSK P43235 8/20 0.42
▸ CTSS P25774 6/20 0.42
▸ ALDH1A1 P00352 3/20 0.41
▸ MAPT P10636 3/20 0.41
▸ CTSL P07711 1/20 0.39
▸ CTSB P07858 1/20 0.39
▸ GSTP1 P09211 1/20 0.39
▸ GSTM2 P28161 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ ALOX12 P18054 1/20 0.39
▸ PPARG P37231 3/20 0.38
▸ PPARA Q07869 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20789083 1.00 CYP1A2 (0.50) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2
SCHEMBL14455148 0.85 CTSS (0.57) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2
SCHEMBL28221788 0.84 CYP1A2 (0.42) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2
SCHEMBL20789039 0.84 CYP1A2 (0.42) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2
SCHEMBL19384756 0.84 CYP1A2 (0.42) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2
SCHEMBL19384808 0.84 CYP1A2 (0.42) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2
SCHEMBL29373981 0.83 CYP1A2 (0.44) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2
SCHEMBL28777391 0.82 CYP1A2 (0.56) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2
SCHEMBL18167329 0.82 CYP1A2 (0.56) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2
SCHEMBL15608320 0.82 CYP1A2 (0.56) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3432934-B1 PRODRUGS OF CYTOTOXIC AGENTS WITH ENZYMATICALLY CLEAVABLE GROUPS Bayer Pharma AG (DE) 2022-02-23 — — EP disclosed
EP-3432934-A1 PRODRUGS OF CYTOTOXIC ACTIVE AGENTS HAVING ENZYMATICALLY CLEAVABLE GROUPS Bayer Pharma Aktiengesellschaft (DE) 2019-01-30 — — EP disclosed
WO-2017162663-A1 PRODRUGS OF CYTOTOXIC ACTIVE AGENTS HAVING ENZYMATICALLY CLEAVABLE GROUPS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-09-28 — — WO disclosed
Send feedback